421 related articles for article (PubMed ID: 15950619)
1. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2.
Wahab NA; Weston BS; Mason RM
Exp Cell Res; 2005 Jul; 307(2):305-14. PubMed ID: 15950619
[TBL] [Abstract][Full Text] [Related]
2. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
4. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
Chen Y; Blom IE; Sa S; Goldschmeding R; Abraham DJ; Leask A
Kidney Int; 2002 Oct; 62(4):1149-59. PubMed ID: 12234285
[TBL] [Abstract][Full Text] [Related]
5. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
6. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.
Xin C; Ren S; Eberhardt W; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2006 Jan; 147(2):164-74. PubMed ID: 16299553
[TBL] [Abstract][Full Text] [Related]
8. Expression of connective tissue growth factor in pancreatic cancer cell lines.
Kwon S; Munroe X; Crawley SC; Lee HY; Spong S; Bradham D; Gum JR; Sleisenger MH; Kim YS
Int J Oncol; 2007 Oct; 31(4):693-703. PubMed ID: 17786299
[TBL] [Abstract][Full Text] [Related]
9. In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury.
Blom IE; van Dijk AJ; Wieten L; Duran K; Ito Y; Kleij L; deNichilo M; Rabelink TJ; Weening JJ; Aten J; Goldschmeding R
Nephrol Dial Transplant; 2001 Jun; 16(6):1139-48. PubMed ID: 11390712
[TBL] [Abstract][Full Text] [Related]
10. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240.
Abdel-Wahab N; Wicks SJ; Mason RM; Chantry A
Biochem J; 2002 Mar; 362(Pt 3):643-9. PubMed ID: 11879191
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy.
Abdel-Wahab N; Weston BS; Roberts T; Mason RM
J Am Soc Nephrol; 2002 Oct; 13(10):2437-45. PubMed ID: 12239232
[TBL] [Abstract][Full Text] [Related]
12. [Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad2 signaling pathway in podocyte in vitro].
Huang HC; Liang Y; Cheng LJ
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):574-7. PubMed ID: 15144593
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
[TBL] [Abstract][Full Text] [Related]
15. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells.
Okado T; Terada Y; Tanaka H; Inoshita S; Nakao A; Sasaki S
Kidney Int; 2002 Oct; 62(4):1178-86. PubMed ID: 12234288
[TBL] [Abstract][Full Text] [Related]
16. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
Stroschein SL; Wang W; Luo K
J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
[TBL] [Abstract][Full Text] [Related]
17. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CCN2/connective tissue growth factor expression in the nucleus pulposus of the intervertebral disc: role of Smad and activator protein 1 signaling.
Tran CM; Markova D; Smith HE; Susarla B; Ponnappan RK; Anderson DG; Symes A; Shapiro IM; Risbud MV
Arthritis Rheum; 2010 Jul; 62(7):1983-92. PubMed ID: 20222112
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.
Crean JK; Furlong F; Finlay D; Mitchell D; Murphy M; Conway B; Brady HR; Godson C; Martin F
FASEB J; 2004 Oct; 18(13):1541-3. PubMed ID: 15319369
[TBL] [Abstract][Full Text] [Related]
20. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
Holmes A; Abraham DJ; Sa S; Shiwen X; Black CM; Leask A
J Biol Chem; 2001 Apr; 276(14):10594-601. PubMed ID: 11152469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
